Document:

ex4_98.htm

    Exhibit 4.98

     

    
 

    

    
      

      First
Floor, Block 3, The Oval, Shelbourne Road, Ballsbridge, Dublin 4,
Ireland.

      Tel:  +353
(0) 1 669 9020   Fax:  +353 (0) 1 669 9028

      

    Letter
of Termination to Non Executive Directors

    

    

    

    Dr
William Mason

    Non-Executive
Director

    

    October
09, 2009

    

    

    Dear
Bill

    

    The Lead
Investors and Abingworth LLP require that you stand down from the board on
closing of the current financing transaction (the “Closing”). The Closing is
expected to occur on or around October 16th,
2009.

    

    As
previously advised, I am pleased to confirm that each retiring non-executive
director will be offered an option over 5000 Ordinary Shares per year of
service; such stock options to vest on Closing and will expire, unless otherwise
exercised, on June 30th, 2011.

    

    This is,
we believe, a fair and final settlement pursuant to your service on the Board of
Directors.  Can I conclude by thanking you for your service and
commitment to the Amarin Board over the past few years.

    

    

    

    Yours
sincerely

    

    

    /s/
Thomas G. Lynch

    Thomas
G. Lynch

    Chairmanex4_99.htm

    Exhibit 4.99

     

    
 

    
      

      First
Floor, Block 3, The Oval, Shelbourne Road, Ballsbridge, Dublin 4,
Ireland.

      Tel:  +353
(0) 1 669 9020   Fax:  +353 (0) 1 669 9028

      

    

    Letter
of Termination to Non Executive Directors

    

    

    

    Mr
Anthony Russell Roberts

    Non-Executive
Director

    

    October
09, 2009

    

    

    Dear
Anthony

    

    The Lead
Investors and Abingworth LLP require that you stand down from the board on
closing of the current financing transaction (the “Closing”). The Closing is
expected to occur on or around October 16th,
2009.

    

    As
previously advised, I am pleased to confirm that each retiring non-executive
director will be offered an option over 5000 Ordinary Shares per year of
service; such stock options to vest on Closing and will expire, unless otherwise
exercised, on June 30th, 2011.

    

    This is,
we believe, a fair and final settlement pursuant to your service on the Board of
Directors.  Can I conclude by thanking you for your service and
commitment to the Amarin Board over the past few years.

    

    

    

    Yours
sincerely

    

    

    /s/
Thomas G. Lynch

    Thomas
G. Lynch

    Chairmanex4_100.htm

     

    Exhibit 4.100

    
 

    
      

      First
Floor, Block 3, The Oval, Shelbourne Road, Ballsbridge, Dublin 4,
Ireland.

      Tel:  +353
(0) 1 669 9020   Fax:  +353 (0) 1 669 9028

      

    

    Letter
of Termination to Non Executive Directors

    

    

    

    Dr John
Climax

    Non-Executive
Director

    

    October
09, 2009

    

    

    Dear
John

    

    The Lead
Investors and Abingworth LLP require that you stand down from the board on
closing of the current financing transaction (the “Closing”). The Closing is
expected to occur on or around October 16th,
2009.

    

    As
previously advised, I am pleased to confirm that each retiring non-executive
director will be offered an option over 5000 Ordinary Shares per year of
service; such stock options to vest on Closing and will expire, unless otherwise
exercised, on June 30th, 2011.

    

    This is,
we believe, a fair and final settlement pursuant to your service on the Board of
Directors.  Can I conclude by thanking you for your service and
commitment to the Amarin Board over the past few years.

    

    

    

    Yours
sincerely

    

    

    /s/
Thomas G. Lynch

    Thomas
G. Lynch

    Chairmanex4_101.htm

     

    Exhibit 4.101

     

    
 

    

    First
Floor, Block 3, The Oval, Shelbourne Road, Ballsbridge, Dublin 4,
Ireland.

    Tel:  +353
(0) 1 669 9020    Fax:  +353 (0) 1 669
9028

    

     

    October
12, 2009

     

    Dr Declan
Doogan

    

    Dear
Declan

     

    I am
pleased to offer you the position of Chief Executive Officer of Amarin
Corporation plc (“the Company”) from 19th October 2009.  Initially,
your appointment will be on an “acting” or “interim” capacity and your
confirmation (or otherwise) in this position is subject to future determination
by the Board of Directors.  You will be named to the position of
President of the Company when such position becomes vacant.

     

    As CEO,
you will be the Company’s principal executive officer and will report to the
Company’s Board of Directors.  The Board may establish such Special or
Standing Committees as it deems appropriate and may, from time to time, delegate
its powers to such a Committee or Committees.

     

    In
recognition of your agreement to become CEO, the Board is pleased to offer you
an option over 1,170,000 American Depositary Shares (“ADSs”) to be granted on
January 1, 2010.  The per share purchase price of such grant will be
determined by reference to the closing price for Amarin ADSs on December 31,
2009 as determined by the closing price on the NASDAQ National
Market.

     

    Such
stock options will vest rateably as set forth below and are subject to the terms
of the Company’s Stock Option Plan.

     

    
      	
              January
      1, 2010

            	
              25%

            
	
              January
      1, 2011

            	
              25%

            
	
              January
      1, 2012

            	
              25%

            
	
              January
      1, 2013

            	
              25%

            

    

     

    Other
terms and conditions of your employment remain unchanged except you will be
aware that a review will be undertaken of the Company’s remuneration and
executive retention policies in the fourth quarter of 2009.

     

    I trust
that these terms are satisfactory and I would be very grateful if you could
signify your approval and consent by return email.

     

    In due
course, the above terms will be included in a revised contract of
employment.

     

    
      
         

      

      
         

        
          

        

      

      
         

      

    

    

     

    

    

    First
Floor, Block 3, The Oval, Shelbourne Road, Ballsbridge, Dublin 4,
Ireland.

    Tel:  +353
(0) 1669 9020    Fax:  +353 (0) 1669
9028

    

    

     

    Very
truly yours,

    

    

    

    /s/ Thomas G.
Lynch

    THOMAS G.
LYNCH

    CHAIRMAN
OF THE BOARD

    

    OCTOBER
12, 2009

    

    

    

    

    I hereby
accept and agree to the terms set out above.

    

    

    

    /s/ Dr. Declan
Doogan

    DR.
DECLAN DOOGAN

    

    

    

    OCTOBER
12, 2009ex4_102new.htm

     

    
       

       

       

       

       

      Exhibit 4.102

       

      
 

      

      
        First
Floor, Block 3, The Oval, Shelbourne Road, Ballsbridge, Dublin 4,
Ireland.

        Tel:  +353
(0) 1 669 9020    Fax:  +353 (0) 1 669
9028

      

      October
12, 2009

       

      Dr. Joseph
Zakrzewski

       

      Dear
Joe

       

      I am
pleased to offer you the position of Special Advisor to the Board of Amarin
Corporation plc (“the
Company”).  This is deemed to be effective from September 15,
2009.

       

      As
Special Adviser, your role and responsibilities will be as from time to time
determined by the Board of Directors.

       

      In
consideration thereof, the Company will pay you a fee of $37,500 per calendar
quarter and will reimburse any travel and out of pocket expenses incurred by you
in the execution of your responsibilities.

       

      In
addition, the Board is pleased to offer you an option over 1,170,000 American
Depositary Shares (“ADSs”) to be granted on
January 1, 2010.  The per share purchase price of such grant will be
determined by reference to the closing price for Amarin ADSs on December 31,
2009 as determined by the closing price on the NASDAQ National
Market.

       

      Such
stock options will vest ratably as set forth below and are subject to the terms
of the Company’s Stock Option Plan (a copy of which is hereto
appended).

       

      
        	
                January
      1, 2010

              	
                25%

              
	
                January
      1, 2011

              	
                25%

              
	
                January
      1, 2012

              	
                25%

              
	
                January
      1, 2013

              	
                25%

              

      

      

      I would
also be very grateful if you could arrange to execute the draft Consulting
Contract provided previously.

       

      I trust
that these terms are satisfactory and I would be very grateful if you could
signify your approval and consent by return email.

       

      Very
truly yours,

       

      /s/ Thomas G. Lynch      

      THOMAS
G. LYNCH

      CHAIRMAN
OF THE BOARD

      

      OCTOBER
12, 2009

       

       

       

      
 

      I hereby
accept and agree to the terms set out above.

       

      /s/ Dr. Joseph
Zakrzewski      

      DR.
JOSEPH ZAKRZEWSKI

      

      OCTOBER
12, 2009ex4_103new.htm

    
       

       

      Exhibit 4.103

      
 

      AMARIN
CORPORATION PLC

      7 Curzon
Street

      London
W1J 5HG, England

      

      

      October
16, 2009

      

      To:         
Thomas G. Lynch

      
 

      Re: Certain Warrant
Matters

      

      Mr.
Lynch:

      

      Reference is made to the Securities
Purchase Agreement, dated as of October 12, 2009, among Amarin Corporation plc
(the “Company”)
and the purchasers set forth on Exhibit A thereto (the “SPA”)  Undefined
capitalized terms used herein have the meanings ascribed thereto in the
SPA.

      

      In connection with the warrants to
purchase Ordinary Shares that are being issued to you as of the date hereof
otherwise than pursuant to the SPA (the “Specified Warrants”),
it is agreed as follows:

      

      1.  You (i) represent that
you are an accredited investor having such knowledge and experience in financial
and business matters as to be capable of evaluating the merits and risks of
receiving the Specified Warrants and have received and reviewed a draft of the
Company's draft Form 20-F for the year ended December 31, 2008 and (ii)
acknowledge that the Specified Warrants are subject to certain transfer
restrictions.

      

      2.  The Company hereby grants
to you registration rights with respect to the resale of Ordinary Shares issued
upon exercise of the Specified Warrants, such registration rights having the
same terms as those contained in Article 6 of the SPA as if the Specified
Warrants had been purchased thereunder.  Notwithstanding the
foregoing, unless the SPA is amended to permit otherwise, (i) you shall not be
entitled to exercise piggy back rights with regard to the registration statement
contemplated by the SPA and (ii) your rights to piggy back on any other
registration statements shall be subordinate to the piggy back rights of the
Purchasers under the SPA.  To the extent permitted, the Company
covenants to register such Ordinary Shares on Form S-8 as promptly as
practicable following the closing of the transactions contemplated by the
SPA.

      

      [signature
pages follow]

      
        
           

        

        
           

          
            

          

        

        
           

        

      

      

      IN
WITNESS WHEREOF, the parties have executed this letter as of the date first
above written.

       

      
        	
                 

                 

                AMARIN
      CORPORATION PLC

                 

                 

                By:
      /s/ Alan
Cooke

                Name: 
      Alan Cooke

                Title:   
      CFO

                 

                 

                 

                 

                 

                /s/
      Thomas G. Lynch

                Thomas
      G. Lynch

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00166-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00166-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00166-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00166-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00166-of-00352.parquet"}], [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00166-of-00352.parquet"}]]